Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.950
+0.050 (1.28%)
May 29, 2026, 4:00 PM EDT - Market closed
Evolent Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,889 | 1,876 | 2,555 | 1,964 | 1,352 | 907.96 | |
Revenue Growth (YoY) | -21.26% | -26.56% | 30.09% | 45.26% | 48.91% | -1.80% |
Cost of Revenue | 1,508 | 1,476 | 2,187 | 1,503 | 1,035 | 657.55 |
Gross Profit | 381.19 | 399.88 | 367.35 | 460.47 | 316.58 | 250.41 |
Selling, General & Admin | 298.28 | 303.87 | 263.05 | 358.11 | 269.27 | 219.5 |
Depreciation & Amortization Expenses | 113.35 | 115.85 | 118.37 | 123.42 | 67.2 | 60.04 |
Other Operating Expenses | 388.68 | 390.3 | 26.42 | 50.16 | -23.52 | 13.28 |
Total Operating Expenses | 800.3 | 810.02 | 407.84 | 531.68 | 312.94 | 292.82 |
Operating Income | -419.12 | -410.14 | -40.49 | -71.21 | 3.64 | -42.41 |
Interest Income | 3.93 | 4.19 | 5.54 | 5.26 | 1.37 | 0.41 |
Interest Expense | -63.95 | -57.47 | -24.72 | -54.21 | -15.57 | -25.43 |
Other Non-Operating Income (Expense) | -18.07 | -71.22 | -3.37 | -82.25 | -51.52 | 37.63 |
Total Non-Operating Income (Expense) | -78.1 | -124.5 | -22.55 | -131.19 | -65.72 | 12.61 |
Pretax Income | -497.21 | -534.64 | -63.04 | -202.41 | -62.08 | -29.8 |
Provision for Income Taxes | -0.69 | -0.13 | -1.41 | -89.37 | -43.38 | 0.48 |
Net Income | -533.78 | -579.4 | -93.45 | -142.26 | -19.16 | -37.6 |
Net Income Attributable to Preferred Dividends | -37.26 | -44.89 | -31.83 | -29.22 | - | - |
Earnings From Discontinued Operations | - | - | - | - | -0.46 | -7.32 |
Net Income to Common | -533.78 | -579.4 | -93.45 | -142.26 | -19.16 | -37.6 |
Shares Outstanding (Basic) | 113 | 114 | 115 | 111 | 94 | 86 |
Shares Outstanding (Diluted) | 113 | 114 | 115 | 111 | 94 | 86 |
Shares Change (YoY) | -1.40% | -0.41% | 3.08% | 18.73% | 8.87% | 1.34% |
EPS (Basic) | -4.76 | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 |
EPS (Diluted) | -4.76 | -5.07 | -0.81 | -1.28 | -0.20 | -0.44 |
Shares Outstanding | 112.48 | 111.6 | 116.56 | 113.89 | 99.96 | 89.22 |
Free Cash Flow | 1.4 | 4.76 | -6.13 | 113.84 | -49.91 | 13.76 |
Free Cash Flow Growth | -70.66% | - | - | - | - | - |
Free Cash Flow Per Share | 0.01 | 0.04 | -0.05 | 1.02 | -0.53 | 0.16 |
Gross Margin | 20.18% | 21.31% | 14.38% | 23.45% | 23.42% | 27.58% |
Operating Margin | -22.19% | -21.86% | -1.58% | -3.63% | 0.27% | -4.67% |
Profit Margin | -26.29% | -28.49% | -2.41% | -5.76% | -1.38% | -3.34% |
FCF Margin | 0.07% | 0.25% | -0.24% | 5.80% | -3.69% | 1.52% |
EBITDA | -305.77 | -294.29 | 77.89 | 52.2 | 70.84 | 17.63 |
EBITDA Margin | -16.19% | -15.68% | 3.05% | 2.66% | 5.24% | 1.94% |
EBIT | -419.12 | -410.14 | -40.49 | -71.21 | 3.64 | -42.41 |
EBIT Margin | -22.19% | -21.86% | -1.58% | -3.63% | 0.27% | -4.67% |
Effective Tax Rate | 0.14% | 0.02% | 2.24% | 44.15% | 69.87% | -1.62% |